UBS Group AG - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$5,695,426
+8.7%
358,880
+29.3%
0.00%0.0%
Q2 2023$5,238,897
+149.8%
277,631
-49.2%
0.00%
+100.0%
Q1 2023$2,097,031
-55.3%
546,102
-42.3%
0.00%
-50.0%
Q4 2022$4,690,612
+575.9%
945,688
+551.3%
0.00%
Q3 2022$694,000
-21.4%
145,191
-26.0%
0.00%
Q2 2022$883,000
-67.9%
196,187
-66.1%
0.00%
-100.0%
Q1 2022$2,753,000
+22.8%
578,502
+91.5%
0.00%0.0%
Q4 2021$2,242,000
+2076.7%
302,097
+1566.7%
0.00%
Q3 2021$103,000
-76.4%
18,125
-72.7%
0.00%
Q2 2021$437,000
-76.6%
66,352
-71.2%
0.00%
-100.0%
Q1 2021$1,867,000
+1712.6%
230,543
+1339.1%
0.00%
Q4 2020$103,000
+71.7%
16,020
-3.3%
0.00%
Q3 2020$60,000
-63.0%
16,572
-53.0%
0.00%
Q2 2020$162,000
-61.6%
35,243
-71.5%
0.00%
Q1 2020$422,000
-60.9%
123,615
-41.5%
0.00%
Q4 2019$1,078,000
+2.0%
211,302
-51.6%
0.00%
Q3 2019$1,057,000
+444.8%
436,613
+389.1%
0.00%
Q2 2019$194,000
-43.3%
89,260
-29.3%
0.00%
Q1 2019$342,000
-79.7%
126,250
-64.0%
0.00%
-100.0%
Q4 2018$1,684,000
+7.1%
350,809
+111.3%
0.00%0.0%
Q3 2018$1,572,000
+63.4%
165,987
+67.9%
0.00%
Q2 2018$962,000
-80.8%
98,856
-79.2%
0.00%
-100.0%
Q1 2018$5,011,000
+647.9%
476,323
+356.1%
0.00%
Q4 2017$670,000
-22.1%
104,437
-7.1%
0.00%
Q3 2017$860,000
-2.4%
112,446
-9.2%
0.00%
Q2 2017$881,000
+127.6%
123,864
+23.9%
0.00%
Q1 2017$387,000
+67.5%
99,967
-11.6%
0.00%
Q4 2016$231,000
-10.8%
113,044
+16.8%
0.00%
Q3 2016$259,000
-39.3%
96,821
-30.1%
0.00%
Q2 2016$427,000
-25.2%
138,606
+106.9%
0.00%
Q1 2016$571,000
-76.7%
66,993
-62.9%
0.00%
-100.0%
Q4 2015$2,453,000
+375.4%
180,782
+236.3%
0.00%
Q3 2015$516,000
-55.6%
53,753
-33.6%
0.00%
Q2 2015$1,163,000
+120.7%
80,919
+37.4%
0.00%
Q1 2015$527,000
-36.4%
58,892
-56.6%
0.00%
Q4 2014$828,000135,6840.00%
Other shareholders
IMMUNOGEN INC shareholders Q4 2020
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders